Not logged inEfficacy and safety of sacituzumab tirumotecan (sac-TMT) plus pembrolizumab in patients with recurrent or metastatic cervical cancer
Wang, J.; An, R.; Huang, Y.; Zhang, J.; Goh, J. C. H.; Jiang, K.; Yu, G.; Chen, L.; Provencher, D. M.; Tang, Y.; Li, G.; Qiu, H.; Akala, B.; Chartash, E.; Zhou, Y.; Jin, X.; Ge, J.; Wu, X.
Share
Save